In vivo axonal transport rates decrease in a mouse model of Alzheimer's disease.

Alzheimer's disease as homeostatic responses to age-related myelin breakdown. Neurobiol Aging (2009) 2.14

Manganese-enhanced MRI: an exceptional tool in translational neuroimaging. Schizophr Bull (2008) 1.30

Defects in mitochondrial dynamics and metabolomic signatures of evolving energetic stress in mouse models of familial Alzheimer's disease. PLoS One (2012) 1.25

Analysis of Alzheimer's disease severity across brain regions by topological analysis of gene co-expression networks. BMC Syst Biol (2010) 1.11

Amyloid precursor protein-induced axonopathies are independent of amyloid-beta peptides. Hum Mol Genet (2008) 1.06

Manganese enhanced MRI (MEMRI): neurophysiological applications. Rev Neurosci (2011) 1.03

Is abnormal axonal transport a cause, a contributing factor or a consequence of the neuronal pathology in Alzheimer's disease? Future Neurol (2009) 1.02

Hyperglycemia induces oxidative stress and impairs axonal transport rates in mice. PLoS One (2010) 1.01

The influence of phospho-τ on dendritic spines of cortical pyramidal neurons in patients with Alzheimer's disease. Brain (2013) 0.99

In vivo functional brain mapping in a conditional mouse model of human tauopathy (tauP301L) reveals reduced neural activity in memory formation structures. Mol Neurodegener (2013) 0.95

Axonal degeneration in Alzheimer's disease: when signaling abnormalities meet the axonal transport system. Exp Neurol (2012) 0.95

Mitochondrial superoxide contributes to blood flow and axonal transport deficits in the Tg2576 mouse model of Alzheimer's disease. PLoS One (2010) 0.94

Quantitative in vivo measurement of early axonal transport deficits in a triple transgenic mouse model of Alzheimer's disease using manganese-enhanced MRI. Neuroimage (2011) 0.94

Axonal degeneration as a therapeutic target in the CNS. Cell Tissue Res (2012) 0.91

Manganese-enhanced magnetic resonance imaging (MEMRI). Methods Mol Biol (2011) 0.89

Axonal transport and neurodegenerative disease: can we see the elephant? Prog Neurobiol (2012) 0.87

Pericellular innervation of neurons expressing abnormally hyperphosphorylated tau in the hippocampal formation of Alzheimer's disease patients. Front Neuroanat (2010) 0.87

Force-velocity curves of motor proteins cooperating in vivo. Cell Biochem Biophys (2008) 0.87

Increased Human Wildtype Tau Attenuates Axonal Transport Deficits Caused by Loss of APP in Mouse Models. Magn Reson Insights (2010) 0.86

Transient focal cerebral ischemia/reperfusion induces early and chronic axonal changes in rats: its importance for the risk of Alzheimer's disease. PLoS One (2012) 0.86

Deficits in axonal transport in hippocampal-based circuitry and the visual pathway in APP knock-out animals witnessed by manganese enhanced MRI. Neuroimage (2012) 0.85

Magnetic resonance imaging of neural circuits. Nat Clin Pract Cardiovasc Med (2008) 0.85

R-flurbiprofen improves axonal transport in the Tg2576 mouse model of Alzheimer's disease as determined by MEMRI. Magn Reson Med (2010) 0.85

Identification of changes in neuronal function as a consequence of aging and tauopathic neurodegeneration using a novel and sensitive magnetic resonance imaging approach. Neurobiol Aging (2017) 0.84

Impact of repeated topical-loaded manganese-enhanced MRI on the mouse visual system. Invest Ophthalmol Vis Sci (2012) 0.84

Convergence of presenilin- and tau-mediated pathways on axonal trafficking and neuronal function. J Neurosci (2010) 0.84

Increasing membrane cholesterol of neurons in culture recapitulates Alzheimer's disease early phenotypes. Mol Neurodegener (2014) 0.83

Neuronal dysfunction of a long projecting multisynaptic pathway in response to methamphetamine using manganese-enhanced MRI. Psychopharmacology (Berl) (2007) 0.83

Manganese-enhanced MRI (MEMRI) via topical loading of Mn(2+) significantly impairs mouse visual acuity: a comparison with intravitreal injection. NMR Biomed (2014) 0.83

Actively Decoupled Transmit-Receive Coil-Pair for Mouse Brain MRI. Concepts Magn Reson Part B Magn Reson Eng (2008) 0.83

Non-invasive, in vivo monitoring of neuronal transport impairment in a mouse model of tauopathy using MEMRI. Neuroimage (2012) 0.83

Comparison of histological techniques to visualize iron in paraffin-embedded brain tissue of patients with Alzheimer's disease. J Histochem Cytochem (2013) 0.82

Axonal degeneration in an Alzheimer mouse model is PS1 gene dose dependent and linked to intraneuronal Aβ accumulation. Front Aging Neurosci (2014) 0.82

Manganese-Enhanced Magnetic Resonance Imaging of Traumatic Brain Injury. J Neurotrauma (2015) 0.81

In vivo axonal transport deficits in a mouse model of fronto-temporal dementia. Neuroimage Clin (2014) 0.81

In vivo detection of excitotoxicity by manganese-enhanced MRI: comparison with physiological stimulation. Magn Reson Med (2011) 0.80

In vivo imaging biomarkers in mouse models of Alzheimer's disease: are we lost in translation or breaking through? Int J Alzheimers Dis (2010) 0.78

Axonal transport rate decreased at the onset of optic neuritis in EAE mice. Neuroimage (2014) 0.77

Antenatal insults modify newborn olfactory function by nitric oxide produced from neuronal nitric oxide synthase. Exp Neurol (2012) 0.77

Laminar specific detection of APP induced neurodegeneration and recovery using MEMRI in an olfactory based Alzheimer's disease mouse model. Neuroimage (2015) 0.76

Manganese-Enhanced MRI: Biological Applications in Neuroscience. Front Neurol (2015) 0.76

Alzheimer's disease biomarkers in animal models: closing the translational gap. Am J Neurodegener Dis (2013) 0.75

Spatial learning and memory impairments are associated with increased neuronal activity in 5XFAD mouse as measured by manganese-enhanced magnetic resonance imaging. Oncotarget (2016) 0.75

In vivo imaging of optic nerve fiber integrity by contrast-enhanced MRI in mice. J Vis Exp (2014) 0.75

Preclinical Magnetic Resonance Imaging and Spectroscopy Studies of Memory, Aging, and Cognitive Decline. Front Aging Neurosci (2016) 0.75

Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science (1996) 19.72

Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J Neurosci (2001) 6.32

Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science (2005) 5.49

In vivo neuronal tract tracing using manganese-enhanced magnetic resonance imaging. Magn Reson Med (1998) 2.36

Alzheimer amyloid protein precursor in the rat hippocampus: transport and processing through the perforant path. J Neurosci (1998) 2.00

Behavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19 months. Physiol Behav (2002) 1.99

Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: a magnetic resonance microscopy and stereologic analysis. Proc Natl Acad Sci U S A (2003) 1.86

Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease. Hum Mol Genet (2004) 1.86

Magnetic resonance imaging of neuronal connections in the macaque monkey. Neuron (2002) 1.82

Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease. Pharmacol Rev (2002) 1.80

Assembly of microtubules at the tip of growing axons. Nature (1986) 1.77

Tracing odor-induced activation in the olfactory bulbs of mice using manganese-enhanced magnetic resonance imaging. Neuroimage (2002) 1.70

In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent. Magn Reson Med (2004) 1.65

MALDI mass spectrometric imaging of biological tissue sections. Mech Ageing Dev (2005) 1.52

In vivo trans-synaptic tract tracing from the murine striatum and amygdala utilizing manganese enhanced MRI (MEMRI). Magn Reson Med (2003) 1.46

Interactions of colchicine with tubulin. Pharmacol Ther (1991) 1.43

Diffusion tensor imaging detects age-dependent white matter changes in a transgenic mouse model with amyloid deposition. Neurobiol Dis (2004) 1.41

Detection of age-dependent brain injury in a mouse model of brain amyloidosis associated with Alzheimer's disease using magnetic resonance diffusion tensor imaging. Exp Neurol (2005) 1.40

MRI assessment of neuropathology in a transgenic mouse model of Alzheimer's disease. Magn Reson Med (2004) 1.37

Changes in extracellular space size and geometry in APP23 transgenic mice: a model of Alzheimer's disease. Proc Natl Acad Sci U S A (2005) 1.35

Glutamate and amyloid beta-protein rapidly inhibit fast axonal transport in cultured rat hippocampal neurons by different mechanisms. J Neurosci (2003) 1.35

Paramagnetic contrast agents in nuclear magnetic resonance medical imaging. Semin Nucl Med (1983) 1.29

Fast axonal transport misregulation and Alzheimer's disease. Neuromolecular Med (2002) 1.28

Noninvasive in vivo MRI detection of neuritic plaques associated with iron in APP[V717I] transgenic mice, a model for Alzheimer's disease. Magn Reson Med (2005) 1.27

Axonal transport of manganese and its relevance to selective neurotoxicity in the rat basal ganglia. Brain Res (1994) 1.26

Improved neuronal tract tracing using manganese enhanced magnetic resonance imaging with fast T(1) mapping. Magn Reson Med (2006) 1.24

Visualization of beta-amyloid plaques in a transgenic mouse model of Alzheimer's disease using MR microscopy without contrast reagents. Magn Reson Med (2004) 1.19

Axonal defects in mouse models of motoneuron disease. J Neurobiol (2004) 1.16

Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer's disease. Acta Neuropathol (2006) 1.16

Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models. Int J Dev Neurosci (2004) 1.12

Neuropsychology of cognitive ageing, minimal cognitive impairment, Alzheimer's disease, and vascular cognitive impairment. Eur J Pharmacol (2004) 1.07

Applications of manganese-enhanced magnetic resonance imaging (MEMRI) to image brain plasticity in song birds. NMR Biomed (2004) 1.07

AbetaPP induces cdk5-dependent tau hyperphosphorylation in transgenic mice Tg2576. J Alzheimers Dis (2002) 1.05

Olfactory involvement in aging and Alzheimer's disease: an autopsy study. J Alzheimers Dis (2005) 1.05

Calcium-regulated signaling pathways: role in amyloid beta-induced synaptic dysfunction. Neuromolecular Med (2004) 0.98

Expression of stress-activated kinases c-Jun N-terminal kinase (SAPK/JNK-P) and p38 kinase (p38-P), and tau hyperphosphorylation in neurites surrounding betaA plaques in APP Tg2576 mice. Neuropathol Appl Neurobiol (2004) 0.98

Temperature-dependence of rapid axonal transport in sympathetic nerves of the rabbit. J Neurobiol (1976) 0.98

Distances between the paclitaxel, colchicine, and exchangeable GTP binding sites on tubulin. Biochemistry (1998) 0.96

Cytoskeletal organization of the developing mouse olfactory nerve layer. J Comp Neurol (2006) 0.92

Quantitative MRI assessment of Alzheimer's disease. J Mol Neurosci (2004) 0.91

Ingested manganese chloride as a contrast agent for magnetic resonance imaging. Magn Reson Imaging (1987) 0.89

Magnetic field dependence of solvent proton relaxation rates induced by Gd3+ and Mn2+ complexes of various polyaza macrocyclic ligands: implications for NMR imaging. Magn Reson Med (1986) 0.87

Magnetic resonance imaging of the rat Harderian gland. J Anat (2002) 0.87

Olfaction in persons with Alzheimer's disease. Neuropsychol Rev (1998) 0.86

Alzheimer pathology in the olfactory bulb. Neuropathol Appl Neurobiol (2005) 0.84

Paramagnetic complexes of manganese(II), iron(III), and gadolinium(III) as contrast agents for magnetic resonance imaging. The influence of stability constants on the biodistribution of radioactive aminopolycarboxylate complexes. Invest Radiol (1987) 0.83

The oral administration of MnCl2: a potential alternative to IV injection for tissue contrast enhancement in magnetic resonance imaging. Magn Reson Imaging (1984) 0.82

Anosmia in Alzheimer disease. Percept Mot Skills (1994) 0.79

Structural and immunohistological modifications in olfactory bulb of the staggerer mutant mouse. Biol Cell (1999) 0.78

Axonal transport in the garfish optic nerve: comparison with the olfactory system. J Neurochem (1988) 0.77

Translating the A1C assay into estimated average glucose values. Diabetes Care (2008) 11.55

The US National Comorbidity Survey Replication (NCS-R): design and field procedures. Int J Methods Psychiatr Res (2004) 10.47

Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination. Vaccine (2009) 6.30

Clinical calibration of DSM-IV diagnoses in the World Mental Health (WMH) version of the World Health Organization (WHO) Composite International Diagnostic Interview (WMHCIDI). Int J Methods Psychiatr Res (2004) 6.04

MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell (2011) 5.91

Glucose levels and risk of dementia. N Engl J Med (2013) 4.95

[Human natural infection of Plasmodium knowlesi]. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi (2006) 3.99

Pancreatic ductal adenocarcinoma: long-term survival does not equal cure. Surgery (2012) 3.87

CD4 decline and incidence of opportunistic infections in Cape Town, South Africa: implications for prophylaxis and treatment. J Acquir Immune Defic Syndr (2006) 3.39

Prospective study of bevacizumab plus temozolomide in patients with advanced neuroendocrine tumors. J Clin Oncol (2012) 3.36

Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci U S A (2004) 2.99

Dimorphic effects of Notch signaling in bone homeostasis. Nat Med (2008) 2.82

Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. J Infect Dis (2009) 2.62

Optimizing resource allocation in United States AIDS drug assistance programs. Clin Infect Dis (2006) 2.45

Presenilin couples the paired phosphorylation of beta-catenin independent of axin: implications for beta-catenin activation in tumorigenesis. Cell (2002) 2.37

The effect of angiotensin-blocking agents on liver fibrosis in patients with hepatitis C. Liver Int (2009) 2.33

Predictors of mortality in patients initiating antiretroviral therapy in Durban, South Africa. S Afr Med J (2008) 2.30

Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Abeta 42 production. Proc Natl Acad Sci U S A (2002) 2.29

Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study. Lancet Oncol (2009) 2.23

Exercise-induced ST-segment elevation in ECG lead aVR is a useful indicator of significant left main or ostial LAD coronary artery stenosis. JACC Cardiovasc Imaging (2011) 2.21

Defective neuromuscular synapses in mice lacking amyloid precursor protein (APP) and APP-Like protein 2. J Neurosci (2005) 2.21

A negative feedback loop of transcription factors that controls stem cell pluripotency and self-renewal. FASEB J (2006) 2.17

Hepatitis C virus infection and its clearance alter circulating lipids: implications for long-term follow-up. Hepatology (2009) 2.13

A comparative effectiveness analysis of three continuous glucose monitors. Diabetes Care (2012) 1.97

Lapsing during sleep deprivation is associated with distributed changes in brain activation. J Neurosci (2008) 1.92

The effects of isoflurane and desflurane on cognitive function in humans. Anesth Analg (2011) 1.88

Acupuncture for migraine prophylaxis: a randomized controlled trial. CMAJ (2012) 1.87

Statistical diffusion tensor histology reveals regional dysmyelination effects in the shiverer mouse mutant. Neuroimage (2005) 1.86

Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and cardiomyopathy. Proc Natl Acad Sci U S A (2006) 1.85

Comparison of positron emission tomography measurement of adenosine-stimulated absolute myocardial blood flow versus relative myocardial tracer content for physiological assessment of coronary artery stenosis severity and location. JACC Cardiovasc Imaging (2009) 1.84

A novel tool for the assessment of pain: validation in low back pain. PLoS Med (2009) 1.75

Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetes. PLoS One (2012) 1.74

Non-high-density lipoprotein cholesterol as a biomarker for nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol (2012) 1.74

The anesthetic considerations of tracheobronchial foreign bodies in children: a literature review of 12,979 cases. Anesth Analg (2010) 1.74

Mortality on Mount Everest, 1921-2006: descriptive study. BMJ (2008) 1.66

Presynaptic and postsynaptic interaction of the amyloid precursor protein promotes peripheral and central synaptogenesis. J Neurosci (2009) 1.65

Presenilin 1 mediates the turnover of telencephalin in hippocampal neurons via an autophagic degradative pathway. J Cell Biol (2004) 1.65

GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype. J Infect Dis (2006) 1.64

Predictors of antiretroviral treatment failure in an urban HIV clinic. J Acquir Immune Defic Syndr (2007) 1.61

Phase 1/2 study of everolimus in advanced hepatocellular carcinoma. Cancer (2011) 1.59

Structural basis for the prion-like MAVS filaments in antiviral innate immunity. Elife (2014) 1.56

Widespread muscle expression of an AAV9 human mini-dystrophin vector after intravenous injection in neonatal dystrophin-deficient dogs. Mol Ther (2010) 1.56

Accelerated plaque accumulation, associative learning deficits, and up-regulation of alpha 7 nicotinic receptor protein in transgenic mice co-expressing mutant human presenilin 1 and amyloid precursor proteins. J Biol Chem (2002) 1.54

Tau loss attenuates neuronal network hyperexcitability in mouse and Drosophila genetic models of epilepsy. J Neurosci (2013) 1.54

Local extension at the hilum region is associated with worse long-term survival in stage I non-small cell lung cancers. Ann Thorac Surg (2011) 1.53

A replicable method for blood glucose control in critically Ill patients. Crit Care Med (2008) 1.50

Bcr-abl signals to desensitize chronic myeloid leukemia cells to IFNα via accelerating the degradation of its receptor. Blood (2011) 1.49

Sequential introduction of reprogramming factors reveals a time-sensitive requirement for individual factors and a sequential EMT-MET mechanism for optimal reprogramming. Nat Cell Biol (2013) 1.47

Metastatic tumors in the pancreas in the modern era. J Am Coll Surg (2010) 1.45

Associations between features of glucose exposure and A1C: the A1C-Derived Average Glucose (ADAG) study. Diabetes (2010) 1.45

Physiological functions of APP family proteins. Cold Spring Harb Perspect Med (2012) 1.44

Distinct rates of palmitate turnover on membrane-bound cellular and oncogenic H-ras. J Biol Chem (2003) 1.43

DTNBP1, a schizophrenia susceptibility gene, affects kinetics of transmitter release. J Cell Biol (2008) 1.42

Obesity and mortality risk: new findings from body mass index trajectories. Am J Epidemiol (2013) 1.42

Triple plasty of bronchus, pulmonary artery, and superior vena cava for non-small cell lung cancer. Ann Thorac Surg (2012) 1.42

Presenilins are required for the formation of comma- and S-shaped bodies during nephrogenesis. Development (2003) 1.40

Soluble amyloid precursor protein (APP) regulates transthyretin and Klotho gene expression without rescuing the essential function of APP. Proc Natl Acad Sci U S A (2010) 1.38

Pancreatic fistula rates after 462 distal pancreatectomies: staplers do not decrease fistula rates. J Gastrointest Surg (2008) 1.38

Wild-type presenilin 1 protects against Alzheimer disease mutation-induced amyloid pathology. J Biol Chem (2006) 1.37

Presenilin-1 regulates intracellular trafficking and cell surface delivery of beta-amyloid precursor protein. J Biol Chem (2002) 1.34

Modulation of gamma-secretase specificity using small molecule allosteric inhibitors. Proc Natl Acad Sci U S A (2009) 1.34

Presenilin 1 regulates epidermal growth factor receptor turnover and signaling in the endosomal-lysosomal pathway. J Biol Chem (2007) 1.32

[A sero-epidemiological study on hepatitis C in China]. Zhonghua Liu Xing Bing Xue Za Zhi (2011) 1.32

Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis. Cancer (2007) 1.30

miR-211 is a prosurvival microRNA that regulates chop expression in a PERK-dependent manner. Mol Cell (2012) 1.27

Identification and characterization of the DNA-binding domain of the multifunctional PutA flavoenzyme. J Biol Chem (2004) 1.25

SynDB: a Synapse protein DataBase based on synapse ontology. Nucleic Acids Res (2006) 1.25

Super high threshold percolative ferroelectric/ferrimagnetic composite ceramics with outstanding permittivity and initial permeability. Angew Chem Int Ed Engl (2009) 1.23

Hepatitis B screening, prophylaxis and re-activation in the era of rituximab-based chemotherapy. Liver Int (2010) 1.22

Suppression of cyclin-dependent kinase 5 activation by amyloid precursor protein: a novel excitoprotective mechanism involving modulation of tau phosphorylation. J Neurosci (2005) 1.21

Hydrodynamic limb vein injection of adeno-associated virus serotype 8 vector carrying canine myostatin propeptide gene into normal dogs enhances muscle growth. Hum Gene Ther (2009) 1.21

Amyolid precursor protein mediates presynaptic localization and activity of the high-affinity choline transporter. Proc Natl Acad Sci U S A (2007) 1.21

Pen2 and presenilin-1 modulate the dynamic equilibrium of presenilin-1 and presenilin-2 gamma-secretase complexes. J Biol Chem (2008) 1.20

Overexpression of SOD-2 reduces hippocampal superoxide and prevents memory deficits in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A (2009) 1.20

Amyloid precursor protein regulates Cav1.2 L-type calcium channel levels and function to influence GABAergic short-term plasticity. J Neurosci (2009) 1.20

Morphine-induced mu-opioid receptor rapid desensitization is independent of receptor phosphorylation and beta-arrestins. Cell Signal (2008) 1.19

Tracking of multimodal therapeutic nanocomplexes targeting breast cancer in vivo. Nano Lett (2010) 1.18

Reduced synaptic vesicle density and active zone size in mice lacking amyloid precursor protein (APP) and APP-like protein 2. Neurosci Lett (2005) 1.17

Phospholipase D1 corrects impaired betaAPP trafficking and neurite outgrowth in familial Alzheimer's disease-linked presenilin-1 mutant neurons. Proc Natl Acad Sci U S A (2006) 1.14

Serum alpha-fetoprotein response as a surrogate for clinical outcome in patients receiving systemic therapy for advanced hepatocellular carcinoma. Oncologist (2009) 1.14

Peroxisome proliferator-activated receptor delta is up-regulated during vascular lesion formation and promotes post-confluent cell proliferation in vascular smooth muscle cells. J Biol Chem (2002) 1.14

Amyloid β-induced impairments in hippocampal synaptic plasticity are rescued by decreasing mitochondrial superoxide. J Neurosci (2011) 1.14

The landscape of accessible chromatin in mammalian preimplantation embryos. Nature (2016) 1.13

Ca2+ sparks and secretion in dorsal root ganglion neurons. Proc Natl Acad Sci U S A (2005) 1.12

Genetic suppression of transgenic APP rescues Hypersynchronous network activity in a mouse model of Alzeimer's disease. J Neurosci (2014) 1.11

Empirically establishing blood glucose targets to achieve HbA1c goals. Diabetes Care (2014) 1.11

Statistical estimates of absenteeism attributable to seasonal and pandemic influenza from the Canadian Labour Force Survey. BMC Infect Dis (2011) 1.11

Amyloid precursor protein revisited: neuron-specific expression and highly stable nature of soluble derivatives. J Biol Chem (2011) 1.09

Upregulated expression of kappa light chain by Epstein-Barr virus encoded latent membrane protein 1 in nasopharyngeal carcinoma cells via NF-kappaB and AP-1 pathways. Cell Signal (2006) 1.08

Anxiolytic effect of wogonin, a benzodiazepine receptor ligand isolated from Scutellaria baicalensis Georgi. Biochem Pharmacol (2002) 1.08

Adverse events associated with acupuncture: three multicentre randomized controlled trials of 1968 cases in China. Trials (2011) 1.07

Regulation of tyrosinase trafficking and processing by presenilins: partial loss of function by familial Alzheimer's disease mutation. Proc Natl Acad Sci U S A (2005) 1.07

Gallbladder lesions identified on ultrasound. Lessons from the last 10 years. J Gastrointest Surg (2011) 1.06

Effect of local tidal lung strain on inflammation in normal and lipopolysaccharide-exposed sheep*. Crit Care Med (2014) 1.06

Calcium- and dynamin-independent endocytosis in dorsal root ganglion neurons. Neuron (2004) 1.06

Hepatitis A surveillance and vaccine use in China from 1990 through 2007. J Epidemiol (2009) 1.06

Trends in presentation and survival for gallbladder cancer during a period of more than 4 decades: a single-institution experience. Arch Surg (2009) 1.06

Gastric cancer in individuals with Li-Fraumeni syndrome. Genet Med (2011) 1.05

Expression of immunoglobulin kappa light chain constant region in abnormal human cervical epithelial cells. Int J Biochem Cell Biol (2004) 1.05

Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's disease. J Neurosci (2010) 1.04